Collaborative Research Group for Necrotizing Enterocolitis

Completed · Not applicable

Conditions studied: Prematurity, Necrotizing Enterocolitis

In brief

This proposal will test the hypothesis that synthesis and catabolism of epidermal growth factor (EGF), the genotype of the EGF gene, and the microbiome interact to influence EGF expression in infants at risk for necrotizing enterocolitis (NEC).

Key facts

Study ID

NCT00828451

Run by

Washington University School of Medicine

People needed

29

Starts

2008-05-01

Expected to finish

2010-12-01

Last updated by the study team

2018-04-04

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• gestation 32 weeks or less
• 1 week of age or less
• intravenous line in place for clinical purposes

You may not qualify if…

• imminent death
• active infection
• pre-existing diagnosis of NEC
• fluid or electrolyte imbalance

Where it is running

• St. Louis Children's Hospital — St Louis, Missouri, United States
• St. Louis Children's Hospital — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.